Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Gains from Investment Securities (2016 - 2019)

Ocugen's (OCGN) quarterly Gains from Investment Securities came in at $5000.0 in Q2 2019, up 100.14% YoY from $2498.2 in Q2 2018, and down 99.64% on a QoQ basis from $1.4 million in Q1 2019.

Analysis

Ocugen (OCGN) Gains from Investment Securities (2016 - 2019) Analysis & Trends

Ocugen (OCGN) has 4 years of Gains from Investment Securities data on file, last reported at $5000.0 in Q2 2019.

  • Quarterly Gains from Investment Securities rose 100.14% year-over-year to $5000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$24.4 million (down 486.11% YoY) and the FY2018 annual result came in at -$20.6 million, down 1490.08% from the prior year.
  • Gains from Investment Securities eased to $5000.0 in Q2 2019, from $1.4 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $8.8 million in Q1 2018 to a low of -$17.8 million in Q3 2018.
  • A 4-year average of -$2.9 million and a median of $70000.0 in 2017 frame the typical range for Gains from Investment Securities.
  • The widest YoY moves for Gains from Investment Securities: up 3153.9% in 2018, down 6708.18% in 2018.
  • Tracing OCGN's Gains from Investment Securities over 4 years: stood at -$17.0 million in 2016, then soared by 104.77% to $809000.0 in 2017, then plunged by 1098.39% to -$8.1 million in 2018, then soared by 100.06% to $5000.0 in 2019.
  • The last three Gains from Investment Securities figures came in at $5000.0 (Q2 2019), $1.4 million (Q1 2019), and -$8.1 million (Q4 2018), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 5,000.00
Mar 31, 2019 1.41 Mn
Dec 31, 2018 -8.08 Mn
Sep 30, 2018 -17.78 Mn
Jun 30, 2018 -3.50 Mn
Mar 31, 2018 8.75 Mn
Dec 31, 2017 809,000.00
Sep 30, 2017 269,000.00
Jun 30, 2017 135,000.00
Mar 31, 2017 269,000.00
Dec 31, 2016 -16.97 Mn
Sep 30, 2016 -539,000.00